News Archives - SOHO Insider

Skip to content

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL
SOHO EAGLE program takes off, expanding access to education globally
Dr. Shulman discusses US cancer surveillance challenges
New blood test diagnoses multiple myeloma noninvasively
Treatment post-relapse improves survival outcomes in patients with AML or MDS

Join SOHO

Follow Us :

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

Cellular Therapy

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

Leukemia

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

Lymphoma

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

Multiple Myeloma

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

Myelodysplastic Syndromes

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

August 18, 2025

Insider Podcast
About
Society Updates
- Society Updates
- Join SOHO
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Meeting News
Multimedia
- Roundtable Discussions
  - MDS Roundtable
  - MPN Roundtable
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library News

Submit

News

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

by SOHO Insider Editors
August 16, 2025
0 Comments

News

New AI tool ‘DeepHeme’ improves blood cancer diagnosis

by Leah Sherwood
August 8, 2025
0 Comments

FDA approved

Lymphoma Multiple Myeloma News

FDA approves biosimilar tocilizumab‑anoh for treatment of CRS

by SOHO Insider Editors
August 7, 2025
0 Comments

FDA stamp on white paper

Lymphoma Indolent B-Cell Lymphomas News

FDA grants priority review for liso-cel in relapsed or refractory MZL

by SOHO Insider Editors
August 5, 2025
0 Comments

European Commission

News

EC approves obe-cel for relapsed or refractory B-ALL

by SOHO Insider Editors
August 4, 2025
0 Comments

Cellular Therapy Lymphoma Aggressive B-Cell Lymphomas Multiple Myeloma News

Can radiation prime the immune system to fight blood cancer?

by Leah Sherwood
August 1, 2025
0 Comments

Beautiful Bright Blue sky with white clouds over the horizon in sunny windy day. Wide Angle Nature sky background, texture for Design. Natural Panoramic cloudy Wallpaper or Web banner With Copy Space

Multiple Myeloma News

Triplet therapy maintains, improves quality of life in relapsed/refractory myeloma

by SOHO Insider Editors
July 31, 2025
0 Comments

Scientists or physicians analyze the blood sample in vitro to prepare a vaccine against a new strain of viruses, Vaccine Research and Science concept.

News

Study backs liso-cel as second-line treatment in transplant-ineligible LBCL

by SOHO Insider Editors
July 30, 2025
0 Comments

Flipping of sheets of calendar with black and red numbers

Multiple Myeloma News

FDA extends review for DREAMM-7, DREAMM-8 therapy in myeloma

by Leah Sherwood
July 24, 2025
0 Comments

SOHO Insider podcast

SOHO 2025 Meeting News Myelodysplastic Syndromes News SOHO Insider Podcast

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

by Leah Sherwood
July 23, 2025
0 Comments

1
2
3
...
11

Top Categories

Cellular Therapy

13

Leukemia

44

Lymphoma

50

Multiple Myeloma

42

Myelodysplastic Syndromes

16

Myeloproliferative Neoplasms

11

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Categories

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Cellular Therapy

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Leukemia

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Lymphoma

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Multiple Myeloma

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Myelodysplastic Syndromes

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Submit

SNDA submitted to FDA for venetoclax, acalabrutinib combo in CLL

SOHO EAGLE program takes off, expanding access to education globally

Dr. Shulman discusses US cancer surveillance challenges

Copyright © 2025 Society of Hematologic Oncology, All rights reserved.